A safety and efficacy study to compare two dosages dabigatran versus warfarin in patients with persistent and long-standing atrial fibrillation undergoing electrical cardioversion.
Phase of Trial: Phase II
Latest Information Update: 26 Aug 2015
At a glance
- Drugs Dabigatran etexilate (Primary) ; Warfarin
- Indications Atrial fibrillation
- Focus Therapeutic Use
- 26 Aug 2015 New trial record